Given the close ties and synergies between the companies, the Groupe Grimaud’s sale of Hubbard has raised a number of questions among Novogen’s clients. We therefore believe it would be useful to confirm the Groupe Grimaud’s commitment to continuing Novogen’s development and providing innovative solutions to the egg industry.
Since it was established in 2008, Novogen has experienced sustained growth. In less than
10 years, it has become one of the market leaders, thanks to a strong product range as a result of its innovative R&D.
Novogen was in fact the first to select animals in collective cages. It was also at the forefront of RFID technologies to select the animals closest to field conditions. Its original genomic programme also significantly speeds up the genetic progress.
Under the leadership of Mickael Le Helloco, the company is now entering a new phase of development.
Its size now gives the company the resources to stand on its own feet and continue to distribute the Novo White and Novo Brown breeders in Europe, the United States and Brazil. In full agreement with Hubbard’s new shareholder, a transition period will ensure that services will continue seamlessly and the future company can be organised effectively.
With the Groupe Grimaud’s backing, Novogen will continue to invest strongly in its R&D, piloted by Thierry Burlot and his team.
The company’s technical sales team is putting in place new resources and Christophe Paté has taken over responsibility for all of the sales partnership worldwide.
Two new subsidiaries are being set up to focus on the American markets: Novogen LLC and Novogen Do Brazil. These subsidiaries will be responsible for delivering breeders and ensuring services continue seamlessly.
Major distribution agreements are currently being finalised.